Spero Therapeutics SPRO
NASDAQ SPRO
$1.02 +0.01 (+0.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Spero Therapeutics (SPRO) Restructuring Costs (2022 - 2025)

Updated

Spero Therapeutics (SPRO) reported Restructuring Costs of $258,000 for FY2025, down 70.6% from $877,000 in FY2024.

Analysis

Spero Therapeutics (SPRO) Restructuring Costs (2022 - 2025) Analysis & Trends

  • Restructuring Costs has a three-year compound annual growth rate of -71.9% (FY2022 to FY2025).
  • According to Business Quant data, Restructuring Costs came in at $877,000 in FY2024 and $11.63 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Spero Therapeutics 58.73 Mn -137.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 83,000.00
Mar 31, 2025 175,000.00
Dec 31, 2024 877,000.00
Dec 31, 2022 -67,000.00
Sep 30, 2022 -152,000.00
Jun 30, 2022 11.85 Mn
API Access

Spero Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=SPRO&period=max&api_key=YOUR_API_KEY